A systematic review of quality and consistency of clinical practice guidelines on the primary prevention of food allergy and atopic dermatitis.
AGREE II
AGREE-REX
Allergy prevention
Applicability
Atopic dermatitis
Clinical practice guideline
Consistency
Eczema
Food allergy
Quality
Systematic review
Journal
The World Allergy Organization journal
ISSN: 1939-4551
Titre abrégé: World Allergy Organ J
Pays: United States
ID NLM: 101481283
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
12
11
2022
revised:
27
03
2023
accepted:
31
03
2023
medline:
12
5
2023
pubmed:
12
5
2023
entrez:
11
5
2023
Statut:
epublish
Résumé
With an increasing number of Clinical Practice Guidelines (CPGs) addressing primary prevention of food allergy and atopic dermatitis, it is timely to undertake a comprehensive assessment of the quality and consistency of recommendations and evaluation of their implementability in different geographical settings. We systematically reviewed CPGs from 8 international databases and extensive website searches. Seven reviewers screened records in any language and then used the AGREE II and AGREE REX instruments to critically appraise CPGs published between January 2011 and April 2022. Our search identified 2138 relevant articles, of which 30 CPGs were eventually included. Eight (27%) CPGs were shortlisted based on our predefined quality criteria of achieving scores >70% in the "Scope and Purpose" and "Rigour of Development" domains of the AGREE II instrument. Among the shortlisted CPGs, scores on the "Applicability" domain were generally low, and only 3 CPGs rated highly in the "Implementability" domain of AGREE-REX, suggesting that the majority of CPGs fared poorly on global applicability. Recommendations on maternal diet and complementary feeding in infants were mostly consistent, but recommendations on use of hydrolysed formula and supplements varied considerably. The overall quality of a CPG for Food Allergy and Atopic Dermatitis prevention did not correlate well with its global applicability. It is imperative that CPG developers consider stakeholders' preferences, local applicability, and adapt existing recommendations to each individual population and healthcare system to ensure successful implementation. There is a need for development of high-quality CPGs for allergy prevention outside of North America and Europe. CRD42021265689.
Sections du résumé
Background and aims
UNASSIGNED
With an increasing number of Clinical Practice Guidelines (CPGs) addressing primary prevention of food allergy and atopic dermatitis, it is timely to undertake a comprehensive assessment of the quality and consistency of recommendations and evaluation of their implementability in different geographical settings.
Methods
UNASSIGNED
We systematically reviewed CPGs from 8 international databases and extensive website searches. Seven reviewers screened records in any language and then used the AGREE II and AGREE REX instruments to critically appraise CPGs published between January 2011 and April 2022.
Results
UNASSIGNED
Our search identified 2138 relevant articles, of which 30 CPGs were eventually included. Eight (27%) CPGs were shortlisted based on our predefined quality criteria of achieving scores >70% in the "Scope and Purpose" and "Rigour of Development" domains of the AGREE II instrument. Among the shortlisted CPGs, scores on the "Applicability" domain were generally low, and only 3 CPGs rated highly in the "Implementability" domain of AGREE-REX, suggesting that the majority of CPGs fared poorly on global applicability. Recommendations on maternal diet and complementary feeding in infants were mostly consistent, but recommendations on use of hydrolysed formula and supplements varied considerably.
Conclusion
UNASSIGNED
The overall quality of a CPG for Food Allergy and Atopic Dermatitis prevention did not correlate well with its global applicability. It is imperative that CPG developers consider stakeholders' preferences, local applicability, and adapt existing recommendations to each individual population and healthcare system to ensure successful implementation. There is a need for development of high-quality CPGs for allergy prevention outside of North America and Europe.
PROSPERO registration number
UNASSIGNED
CRD42021265689.
Identifiants
pubmed: 37168277
doi: 10.1016/j.waojou.2023.100770
pii: S1939-4551(23)00030-3
pmc: PMC10165145
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100770Informations de copyright
© 2023 The Authors.
Références
J Allergy Clin Immunol. 2008 Jun;121(6):1442-7
pubmed: 18539195
J Allergy Clin Immunol. 2017 Jan;139(1):29-44
pubmed: 28065278
Allergol Select. 2022 Mar 4;6:61-97
pubmed: 35274076
World Allergy Organ J. 2022 Sep 12;15(9):100679
pubmed: 36185546
Cochrane Database Syst Rev. 2021 Feb 5;2:CD013534
pubmed: 33545739
Lancet. 2003 May 31;361(9372):1869-71
pubmed: 12788576
Am J Clin Nutr. 2007 Mar;85(3):788-95
pubmed: 17344501
World Allergy Organ J. 2016 Mar 01;9:10
pubmed: 26962387
J Allergy Clin Immunol Pract. 2022 Nov;10(11):2875-2877
pubmed: 35810111
Allergy. 2021 Aug;76(8):2641-2643
pubmed: 33147358
Lancet. 2020 Mar 21;395(10228):962-972
pubmed: 32087126
J Allergy Clin Immunol Pract. 2021 Jan;9(1):22-43.e4
pubmed: 33250376
Nutrients. 2019 Jun 26;11(7):
pubmed: 31248015
J Allergy Clin Immunol. 2013 Apr;131(4):1109-16, 1116.e1-6
pubmed: 23453797
J Allergy Clin Immunol. 2017 May;139(5):1621-1628.e8
pubmed: 27742394
BMJ. 2016 Mar 08;352:i974
pubmed: 26956579
Allergy. 2014 May;69(5):590-601
pubmed: 24697491
Clin Exp Allergy. 2009 Apr;39(4):571-8
pubmed: 19134020
Pediatr Allergy Immunol. 2010 Feb;21(1 Pt 1):29-37
pubmed: 20003068
PLoS One. 2013 Dec 09;8(12):e82915
pubmed: 24349397
J Allergy Clin Immunol. 2016 Apr;137(4):1071-1078
pubmed: 26897122
Lancet. 2017 Jan 21;389(10066):276-286
pubmed: 27939035
Lancet. 2001 Apr 7;357(9262):1076-9
pubmed: 11297958
J Allergy Clin Immunol. 2017 May;139(5):1600-1607.e2
pubmed: 27554812
N Engl J Med. 2016 May 5;374(18):1733-43
pubmed: 26943128
Pediatrics. 2008 Apr;121(4):e850-6
pubmed: 18332075
Allergol Int. 2020 Jul;69(3):370-386
pubmed: 33289637
Lancet. 2020 Mar 21;395(10228):951-961
pubmed: 32087121
J Allergy Clin Immunol. 2007 Apr;119(4):1019-21
pubmed: 17289135
JAMA Netw Open. 2020 May 1;3(5):e205535
pubmed: 32459354
Allergy. 2013 Feb;68(2):220-8
pubmed: 23253182
Lancet. 2020 Mar 21;395(10228):923-924
pubmed: 32087123
J Allergy Clin Immunol. 2003 Mar;111(3):533-40
pubmed: 12642834
Pediatr Allergy Immunol. 2018 Feb;29(1):18-27
pubmed: 29068090
J Allergy Clin Immunol. 2014 Oct;134(4):824-830.e6
pubmed: 25282564
J Allergy Clin Immunol. 2017 May;139(5):1591-1599.e2
pubmed: 27523961
J Allergy Clin Immunol. 2021 Jan;147(1):224-232.e8
pubmed: 32890574
Lancet. 2022 Jun 25;399(10344):2398-2411
pubmed: 35753340
J Allergy Clin Immunol Pract. 2022 Oct;10(10):2657-2666.e8
pubmed: 35987995
World Allergy Organ J. 2016 May 17;9:17
pubmed: 27274360
J Allergy Clin Immunol. 2013 Jun;131(6):1565-73
pubmed: 23506844
Pediatrics. 2008 Jan;121(1):183-91
pubmed: 18166574
Hong Kong Med J. 2016 Jun;22(3):279-85
pubmed: 27305695
World Allergy Organ J. 2016 Aug 18;9:28
pubmed: 27583103
Allergy. 2022 Jun;77(6):1685-1699
pubmed: 34591995
J Allergy Clin Immunol. 2007 Jan;119(1):184-91
pubmed: 17208600
JAMA Pediatr. 2019 Dec 1;173(12):1137-1145
pubmed: 31633778
J Pediatr. 2019 Jun;209:139-145.e1
pubmed: 30902420
N Engl J Med. 2015 Feb 26;372(9):803-13
pubmed: 25705822
Allergy. 2015 Oct;70(10):1193-5
pubmed: 26148305
J Allergy Clin Immunol Pract. 2013 Jan;1(1):29-36
pubmed: 24229819
Curr Allergy Asthma Rep. 2021 Jun;22(6):61-66
pubmed: 35394609
Pediatrics. 2012 Nov;130(5):e1128-35
pubmed: 23090338
J Allergy Clin Immunol Pract. 2022 Jan;10(1):172-179
pubmed: 34403836
Allergy Asthma Clin Immunol. 2017 Feb 8;13:7
pubmed: 28194188
World Allergy Organ J. 2021 May 29;14(6):100550
pubmed: 34141050
Asia Pac Allergy. 2017 Apr;7(2):102-114
pubmed: 28487842
Pediatr Allergy Immunol. 2021 Jul;32(5):843-858
pubmed: 33710678
Allergy Asthma Clin Immunol. 2014 Sep 02;10(1):45
pubmed: 25908933
Ann Allergy Asthma Immunol. 2009 Dec;103(6):488-95
pubmed: 20084842
JAMA Netw Open. 2020 Jul 1;3(7):e2010511
pubmed: 32667655
J Allergy Clin Immunol. 2014 Oct;134(4):818-23
pubmed: 25282563
World Allergy Organ J. 2015 Jan 27;8(1):4
pubmed: 25628773